SCHEMBL7991646

SCHEMBL7991646

Oc1cccc(-c2nc(O)c3c(ncn3Cc3cccc(Cl)c3)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
GLA P06280 1/20 0.43
HTT P42858 1/20 0.43
UBE2N P61088 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ACP1 P24666 1/20 0.41
YTHDC1 Q96MU7 3/20 0.40
KDM4E B2RXH2 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
HTR6 P50406 1/20 0.38
FSCN1 Q16658 1/20 0.37
HSD17B13 Q7Z5P4 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
PIK3CA P42336 1/20 0.37
MTOR P42345 1/20 0.37
PIK3CG P48736 1/20 0.37
CNR2 P34972 1/20 0.37
MAPK1 P28482 1/20 0.36
BRD4 O60885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973626 0.94 SMN1; SMN2 (0.45) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988668 0.91 SMN1; SMN2 (0.44) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7985336 0.91 PIK3CA (0.42) SMN1; SMN2L3MBTL1HSD17B13HDAC1HDAC6
SCHEMBL7991566 0.90 ACP1 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7974012 0.90 ALDH1A1 (0.41) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7987310 0.89 YTHDC1 (0.41) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7985360 0.87 POLB (0.40) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7975240 0.87 ALDH1A1 (0.42) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7974267 0.87 SMN1; SMN2 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991635 0.87 IDO1 (0.37) HSD17B13HDAC1HDAC6PIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed